Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chitosan-Hyaluronate Gel vs Hyaluronic Acid for TMJ Internal Derangement
NCT06426199Phase 4
Key facts
- Status
- Recruiting
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Countries
- 1
- Sponsor
- Ain Shams University
- Conditions
- temporomandibular joint internal derangement (TMJID)
01
Overview
Phase 4, randomised trial of Chitosan-hyaluronate gel mixture in temporomandibular joint internal derangement (TMJID) (2 arms), sponsored by Ain Shams University. Primary endpoints: Joint Pain at 3 months, Maximum lateral jaw movement at 3 months and 2 more. Started Jan 2024; status: recruiting.
02
Design
2 arms- Study design
- Randomized
Chitosan-Hyaluronate Gel Mixture
Arthroscope-guided injection of 2 ml chitosan-hyaluronate gel mixture.
Hyaluronic Acid
Arthroscope-guided injection of 2 ml hyaluronic acid.
03
Who it enrols
Adults aged 25-50 diagnosed with Wilkes Stage III or IV TMJ internal derangement (anterior disc displacement without reduction) who have failed conservative treatment.
04
Endpoints
Primary
Joint Pain
Maximum lateral jaw movement
Temporomandibular joint sounds
Maximum mouth opening
Beyond the preview
Go deeper on NCT06426199.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06426199.